EcoDrugPlus

Ensembl ID : ENSJJAG00000010774
Gene Symbol: -
Cross references: -
55 Possible Orthologues:

Ensembl ID : ENSJJAG00000016532
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSJJAG00000001121
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSJJAG00000004115
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSJJAG00000014461
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSJJAG00000019132
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSJJAG00000007660
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSJJAG00000013592
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSJJAG00000004898
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSJJAG00000001778
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSJJAG00000024176
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSJJAG00000023671
Gene Symbol: -
Cross references: -
57 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).